The Personal Antipsychotic Choice Index

Pharmacopsychiatry. 2018 May;51(3):89-99. doi: 10.1055/s-0043-116854. Epub 2017 Aug 15.

Abstract

Introduction: We present an online decision aid to involve patients with a psychotic disorder in shared decision-making concerning the selection of antipsychotic medication.

Method: Patients selected effectiveness and adverse effects criteria from the Subject's Response to Antipsychotics-34 questionnaire. Numerical data from meta-analyses, clinical trial data, receptor affinities and expert opinions were used to rank antipsychotics on each criterion. When using the the tool, patients indicate on a 5-point Likert scale how they value each (adverse) effect. The Likert scale values are combined in an algorithm with the rank orders of antipsychotics to create a personalized ranking.

Results: Criteria used were: effectiveness concerning psychotic, depressive and cognitive symptoms, weight gain, sexual dysfunction, drowsiness, hypersomnia, extrapyramidal symptoms, anticholinergic adverse effects, hypersalivation, nausea, dizziness, energy loss, blunted affect/less need for companionship. High-level evidence was available for ranking weight gain, sexual dysfunction, menstrual disorders, extrapyramidal symptoms and effectiveness on psychotic symptoms. We used lower level evidence ranking the remaining criteria.

Discussion: A transparent procedure has resulted in an updateable tool to produce individual ranking of antipsychotics based on the patients' input.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Algorithms
  • Antipsychotic Agents / therapeutic use*
  • Databases, Bibliographic / statistics & numerical data
  • Decision Making*
  • Female
  • Humans
  • Male
  • Patient Compliance
  • Psychotic Disorders / drug therapy*
  • Psychotic Disorders / psychology*

Substances

  • Antipsychotic Agents